CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 107 filers reported holding CLOVIS ONCOLOGY INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $50,634,000 | +23.2% | 1,139,890 | 0.0% | 2.01% | +9.2% |
Q3 2016 | $41,093,000 | +162.8% | 1,139,890 | 0.0% | 1.84% | +127.1% |
Q2 2016 | $15,639,000 | -28.5% | 1,139,890 | 0.0% | 0.81% | -44.1% |
Q1 2016 | $21,886,000 | -45.1% | 1,139,890 | 0.0% | 1.45% | -42.8% |
Q4 2015 | $39,896,000 | -61.9% | 1,139,890 | 0.0% | 2.54% | -63.2% |
Q3 2015 | $104,824,000 | +4.6% | 1,139,890 | 0.0% | 6.91% | +32.0% |
Q2 2015 | $100,174,000 | -40.8% | 1,139,890 | -50.0% | 5.23% | -31.6% |
Q1 2015 | $169,228,000 | +32.6% | 2,279,781 | 0.0% | 7.65% | +23.6% |
Q4 2014 | $127,668,000 | +23.5% | 2,279,781 | 0.0% | 6.19% | +17.8% |
Q3 2014 | $103,411,000 | +9.5% | 2,279,781 | 0.0% | 5.26% | +18.7% |
Q2 2014 | $94,406,000 | -40.2% | 2,279,781 | 0.0% | 4.43% | -42.9% |
Q1 2014 | $157,920,000 | +14.9% | 2,279,781 | 0.0% | 7.75% | +16.8% |
Q4 2013 | $137,402,000 | -0.9% | 2,279,781 | 0.0% | 6.64% | +20.9% |
Q3 2013 | $138,611,000 | -9.2% | 2,279,781 | 0.0% | 5.49% | -19.5% |
Q2 2013 | $152,700,000 | – | 2,279,781 | – | 6.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |